MDA-MB-231 cells were used to determine genes differentially regulated by riluzole, a drug currently used to treat ALS patients Overall design: The triple-negative breast cancer cell line, MDA-MB-231,
Figure S1. The optimal cut-off values of NR1B2 via MedCalc software. Figure S2. GSEA analysis of NR1B2 in TCGA. Table S5. the NR1B2 expression in TCGA. Table S6. The sequences of oligonucleotides. Tab
